| Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus (NCT04195243) | Centro Universitario de Ciencias de la Salud, Mexico | 2019-12-02 |
| Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China (NCT04129424) | Peking Union Medical College Hospital | 2019-12-01 |
| Effect of Pre-meal Serving of Dairy and Dairy Alternatives on Post-meal Satiety and Glycaemia in Healthy Young Adults (NCT04600128) | University of Toronto | 2019-11-18 |
| Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) (NCT04029480) | Merck Sharp & Dohme LLC | 2019-10-08 |
| Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus (NCT04120623) | Nanjing First Hospital, Nanjing Medical University | 2019-10-01 |
| Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism (NCT03887936) | VA Office of Research and Development | 2019-10-01 |
| Diabetes Management Program for Hispanic/Latino (NCT03960424) | Northwell Health | 2019-09-30 |
| A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide (NCT04091373) | MedImmune LLC | 2019-09-27 |
| Metabolic Effects of Melatonin Treatment (NCT03859934) | University of Aarhus | 2019-09-26 |
| The MILESTONE Study (NCT04086043) | Zhongda Hospital | 2019-09-10 |
| Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus (NCT04014192) | Peking Union Medical College Hospital | 2019-09-01 |
| Women and Risk of Type 2 Diabetes (NCT03870724) | University of Oslo | 2019-08-27 |
| A Study to Evaluate the DDI of HSK7653 With Metformin (NCT06084156) | Haisco Pharmaceutical Group Co., Ltd. | 2019-08-10 |
| Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes (NCT04047537) | Pendulum Therapeutics | 2019-08-06 |
| Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen (NCT04013581) | Yonsei University | 2019-08-05 |
| Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea (NCT03770728) | Sanofi | 2019-08-01 |
| The Application and Evaluation of eHealth Literacy (eHL) Concept (NCT05180604) | National Yang Ming Chiao Tung University | 2019-08-01 |
| Development of Diabetes Mobile Application (NCT04686201) | National University of Malaysia | 2019-08-01 |
| An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I) (NCT03864432) | LG Chem | 2019-07-02 |
| Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive (NCT03794336) | Sanofi | 2019-06-29 |
| Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus (NCT03948347) | First Affiliated Hospital of Jinan University | 2019-06-25 |
| Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus (NCT06061510) | Southeast University, China | 2019-06-08 |
| A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (NCT03954834) | Eli Lilly and Company | 2019-06-03 |
| A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus (NCT03962010) | Genexine, Inc. | 2019-06-01 |
| Effects of Short-term Intensive Insulin Therapy on Long-term Complications in Type 2 Diabetes (NCT03909555) | Sun Yat-sen University | 2019-06-01 |
| A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes (NCT03952143) | Eli Lilly and Company | 2019-05-27 |
| Effects of Mulberry Leaves on Glycemic Control in Patients With Obesity and Patients With Type 2 Diabetes (NCT04691219) | Chulalongkorn University | 2019-05-26 |
| Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease (NCT03437720) | Sanofi | 2019-05-23 |
| Face-it: Health Promotion for Women With Prior Gestational Diabetes (NCT03997773) | Steno Diabetes Center Copenhagen | 2019-05-16 |
| SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease (NCT03919656) | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2019-05-12 |
| Acute Mycoprotein Effect on Glycaemic Control in South Asians (NCT03949582) | Imperial College London | 2019-05-01 |
| Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy. (NCT03961659) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2019-05-01 |
| Cadence and Intensity in Adults With Type 2 Diabetes (NCT03940937) | University of Massachusetts, Amherst | 2019-05-01 |
| Immunometabolism in Pediatric Obesity (NCT03960333) | Arkansas Children's Hospital Research Institute | 2019-04-25 |
| BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients (NCT03943940) | Van Hanh General Hospital | 2019-04-24 |
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers (NCT04324424) | Hua Medicine Limited | 2019-04-23 |
| Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira (NCT03862716) | Population Health Research Institute | 2019-04-23 |
| The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375 (NCT03848637) | Chong Kun Dang Pharmaceutical | 2019-04-14 |
| Mobile-based Lifestyle Intervention in Women With Glucose Intolerance After Gestational Diabetes (NCT03559621) | Universitaire Ziekenhuizen KU Leuven | 2019-04-14 |
| Malaysia Diabetes Ramadan Nutrition Plan (My Dia-RNP®): A Feasibility Study (NCT03817099) | Universiti Putra Malaysia | 2019-04-01 |
| A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes (NCT03882970) | Eli Lilly and Company | 2019-04-01 |
| Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial (NCT03871621) | Mackay Memorial Hospital | 2019-04-01 |
| A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes (NCT03861039) | Eli Lilly and Company | 2019-03-30 |
| Remission Through Early Monitored Insulin Therapy - Duration Month (NCT03670641) | Sandra Sobel | 2019-03-26 |
| Joint Position Sense, Plantar Sensation, Balance and Dual Task Performance in Individuals With Type 2 Diabetes (NCT03885869) | Ankara Yildirim Beyazıt University | 2019-03-25 |
| Low Carbohydrate Diet in Diabetic Kidney Disease (NCT04931030) | Universiti Teknologi Mara | 2019-03-15 |
| Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes (NCT03818581) | Massachusetts General Hospital | 2019-03-15 |
| Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM) (NCT03767543) | Sanofi | 2019-03-11 |
| Compliance of Diabetic Patients Treated With Metformin (NCT03864705) | Institute for Clinical and Experimental Medicine | 2019-03-01 |
| Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin (NCT03608358) | AstraZeneca | 2019-02-27 |
| Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2 (NCT03782259) | University of Washington | 2019-02-26 |
| Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19 (NCT03867656) | University of Copenhagen | 2019-02-26 |
| The Interaction Between Metformin and Microbiota - the MEMO Study. (NCT03718715) | Umeå University | 2019-02-20 |
| Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin (NCT03798080) | Sanofi | 2019-02-19 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults (NCT03849495) | Chong Kun Dang Pharmaceutical | 2019-02-19 |
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers (NCT04426708) | Hua Medicine Limited | 2019-02-18 |
| Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s) (NCT03798054) | Sanofi | 2019-02-15 |
| Network-based Approach in Type 2 Diabetes and Its Cardiovascular Risk (NCT03792607) | Giuditta Benincasa | 2019-02-14 |
| Web-based Approach in Nutrition and Diabetes (NCT04386200) | Università degli Studi 'G. d'Annunzio' Chieti e Pescara | 2019-02-13 |
| Effect of Eating Within a Limited Time on Sugar Sensitivity and Liver Sugar Stores of People With Type 2 Diabetes. (NCT03992248) | Maastricht University | 2019-01-31 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition (NCT03849339) | Chong Kun Dang Pharmaceutical | 2019-01-28 |
| A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions (NCT03776227) | Sanofi | 2019-01-25 |
| Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial (NCT04535960) | University Health Network, Toronto | 2019-01-24 |
| Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM (NCT06059326) | Haisco Pharmaceutical Group Co., Ltd. | 2019-01-22 |
| Behavioral Economics Applications to Geriatrics Leveraging EHRs (NCT03704389) | Northwestern University | 2019-01-17 |
| The Healthy Eating with APP TechnologY Study (NCT03784612) | Karolinska Institutet | 2019-01-15 |
| Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects (NCT03802487) | Sanofi | 2019-01-14 |
| Time Restricted Eating As Treatment (TREAT) for Diabetes Mellitus: A Pre-Post 12 Week Study on the Effectiveness of Intermittent Fasting in Asians With Type 2 Diabetes Mellitus (NCT03940482) | Singapore General Hospital | 2019-01-14 |
| Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM (NCT05037045) | The Affiliated Hospital of Xuzhou Medical University | 2019-01-10 |
| The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition (NCT03738449) | Chong Kun Dang Pharmaceutical | 2019-01-08 |
| A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus (NCT03745937) | MedImmune LLC | 2019-01-07 |
| Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1 (NCT03560323) | The University of Texas Health Science Center at San Antonio | 2019-01-07 |
| A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients (NCT03805191) | Qilu Hospital of Shandong University | 2019-01-01 |
| Herbal Tea in the Treatment of Type 2 Diabetes Mellitus (NCT03787563) | Composite Interceptive Med Science | 2019-01-01 |
| Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin (NCT03760991) | Sanofi | 2018-12-18 |
| Exercise Volume and Beta-cell Function in T2D The DOSE-EX Randomized Trial (NCT03769883) | Mathias Ried-Larsen | 2018-12-12 |
| Effects of Aerobic Training on Pancreatic Fat and Cognitive Function in T2DM Patients (NCT04489966) | Nanjing University of Traditional Chinese Medicine | 2018-12-01 |
| WellStart Reboot Study (NCT03731533) | Ohio University | 2018-12-01 |
| Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea (NCT03761134) | Sanofi | 2018-11-30 |
| The Effect of Chlorella Supplementation on Patients With Type 2 Diabetes Mellitus (NCT03625856) | Dr. Behnood Abbasi | 2018-11-30 |
| Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise (NCT03760965) | Sanofi | 2018-11-27 |
| Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients (NCT03705260) | University of Michigan | 2018-11-26 |
| A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk (NCT03730662) | Eli Lilly and Company | 2018-11-20 |
| A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus (NCT03736785) | Eli Lilly and Company | 2018-11-15 |
| Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus (NCT03510624) | Universitaire Ziekenhuizen KU Leuven | 2018-11-09 |
| Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) (NCT03713684) | Sanofi | 2018-11-09 |
| Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT). (NCT03541096) | Kristian Karstoft | 2018-11-07 |
| Text Messaging and Cardiovascular Health in Diabetes Mellitus (NCT03724526) | Nanfang Hospital, Southern Medical University | 2018-11-01 |
| Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus (NCT03867500) | Mayo Clinic | 2018-11-01 |
| Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital Discharge (NCT04277780) | Albert Einstein Healthcare Network | 2018-10-31 |
| Diabetes, Exercise and Liver Fat (DELIVER) (NCT04004273) | James King | 2018-10-30 |
| Investigating the Acute Effect of Alternative Forms of Physical Activity in a Multi-ethnic Population (NCT03549390) | University of Leicester | 2018-10-30 |
| Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie (NCT03770052) | Pusan National University Hospital | 2018-10-24 |
| Medical Care, Education, Social Support, And Goal-setting to Empower Self-management for Diabetes (NCT03487692) | University of Chicago | 2018-10-18 |
| Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM (NCT03597412) | Yuhan Corporation | 2018-10-17 |
| Simplified Insulin Regimen for the Elderly (NCT03660553) | University of Miami | 2018-10-10 |
| Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid (NCT03430310) | University of Alabama at Birmingham | 2018-10-09 |
| Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals. (NCT04763525) | National and Kapodistrian University of Athens | 2018-10-04 |
| Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study (NCT03584217) | University of Colorado, Denver | 2018-10-01 |
| Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes (NCT03620773) | University of Colorado, Denver | 2018-10-01 |